OIS XIV Speakers
Dr. Anupam Dalal is a Chief Investment Officer at Acuta Capital Partners LLC. He is responsible for managing healthcare investments, with a focus on biotech.…
Read MoreAndrew joined the Firm in 2024 from Raymond James & Associates where he most recently served as a Senior Managing Director and Vice Chairman in…
Read MoreDavid is an experienced healthcare executive who has built and scaled multiple companies that resulted in successful exits to strategic buyers. David is currently the…
Read MoreJames is a co-founder and partner at ExSight Ventures where he has helped lead the firm’s investments in nine transformative ophthalmic companies. In addition to…
Read MoreErin Henry, Ph.D. is a biotech executive/clinical researcher and strategist. Her most recent role was VP, Product Strategy & Project Team Lead Development at Iveric,…
Read MoreDr. Adrienne Graves is a visual scientist by training and a global industry leader in ophthalmology. Dr. Graves was CEO of Santen Inc (2002-2010) following…
Read MoreDr. Robert Rothman is a board-certified ophthalmologist and Clinical Assistant Professor of Ophthalmology at the Hofstra Northwell School of Medicine and has 18 years of…
Read MoreAndrew Stewart has more than 25 years of experience in the pharmaceutical industry. He joined Bausch + Lomb from AbbVie, where he most recently served…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.